July 2025 in “Agroindustrial Technology Journal” In this study, researchers evaluated shampoo formulations with varying concentrations of rosemary essential oil, finding that the 2% formulation was most preferred based on sensory tests, and complied well with quality standards, indicating its potential as an effective component in hair care products.
May 2025 in “The Journal of Rheumatology” This study reports that even minimal improvements in SLE-related fatigue and skin symptoms are meaningful to patients, supporting the content validity of the FACIT-Fatigue scale for measuring these effects.
May 2025 in “Journal of Dispersion Science and Technology” This study reported that a novel SMEDDS formulation of PPO demonstrated better permeation and improved hair growth compared to a marketed formulation in tests for managing androgenetic alopecia, with further exploration suggested.
April 2025 in “Journal of Reproductive Healthcare and Medicine” This study confirmed that an injectable implant known as RISUG-PH™, when administered via the vas deferens, successfully delivers the drug Finasteride to the prostate in male rats for up to 28 days, suggesting a potential localized alternative to oral delivery methods.
April 2025 in “International Journal of Homoeopathic Sciences” This case report suggests that individualized homeopathic therapy with Carcinosin may benefit pediatric patients with alopecia areata by improving hair regrowth and psychological symptoms, as supported by standardized assessment tools.
January 2025 in “Scholars Journal of Medical Case Reports” In this study, a 37-year-old Moroccan man experienced hair loss after two months of quetiapine treatment for major depressive disorder, which resolved after discontinuation, highlighting the need for awareness of this potential rare side effect.
January 2025 in “Journal of Dermatology & Dermatologic Surgery” This study found that patients with telogen effluvium had a higher quality of life score compared to controls, despite no significant difference in self-esteem.
January 2025 in “Therapeutic Advances in Medical Oncology” This study found that many young women with breast cancer experience a poor quality of life over time, especially regarding sexual health, future perspective, and hair loss.
January 2025 in “ARC Journal of Dermatology” In this study, researchers observed significant racial disparities in alopecia quality of life research, with fewer studies and less funding focusing on Black patients compared to other racial groups, indicating a need for more inclusive and diverse participant recruitment.
January 2025 in “Journal of Bioresource Management” This study found that inhibiting the ATR kinase with VE-822 impairs DNA repair capability in quiescent human keratinocytes exposed to solar-simulated UV radiation, suggesting ATR's critical role in facilitating effective DNA damage repair and cellular recovery under UV stress conditions.
December 2024 in “Naunyn-Schmiedeberg s Archives of Pharmacology” December 2024 in “Caderno Pedagógico” This review found limited scientific evidence on the importance of scalp health for successful hair transplants, with most care recommendations based on surgeons' opinions.
November 2024 in “Psychology Health & Medicine” This study identified subgroups of people with alopecia areata with varying levels of quality of life impairment, influenced by feelings of flaw, coping styles, and social factors.
November 2024 in “Journal of Microscopy” This study found that micro-computed tomography (micro-CT) was highly effective for analyzing the cross-sectional geometry of hair fibres, including the medulla in highly curled hair, but less effective than scanning electron microscopy for surface details.
November 2024 in “IP Indian Journal of Clinical and Experimental Dermatology” In this study, researchers reported that alopecia areata significantly impacts quality of life, with effects ranging from small to very large, especially for those with longer disease duration, highlighting the importance of psychological evaluation and support for affected patients.
October 2024 in “International Journal of Pharma Professional’s Research (IJPPR)” This study developed and characterized Quercetin-loaded nanogels, finding that they showed promising potential for enhanced drug delivery and stability in treating Alopecia, with an optimized batch achieving a drug release of 95.32% over 12 hours.
October 2024 in “INNOVATION RESEARCH JOURNAL” This study found a significant relationship between the severity of acne vulgaris and the quality of life among adolescents in Gresik, with many experiencing severe disturbances in quality of life related to more severe acne.
September 2024 in “International Journal For Multidisciplinary Research” In this observational study conducted in a dermatology outpatient setting, the researchers reported that minoxidil 5% was the most commonly prescribed treatment for androgenic alopecia, with male patients experiencing a greater impact on quality of life compared to females.
September 2024 in “Journal of Cosmetic Dermatology” This study found that quercetin-loaded solid lipid nanoparticles demonstrated positive protective effects on human hair against UV-B light, as they controlled microscopic surface roughness, reduced chemical changes, and minimized protein loss in vitro compared to other treatments.
September 2024 in “Journal of the American Academy of Dermatology” In this study, Muslim women with alopecia who wear hijab generally reported a lesser impact on quality of life than those who do not wear hijab, and were less likely to seek medical care for their condition.
September 2024 in “Heliyon” In this study, researchers observed that even a single session of hair dyeing can damage hair fibers, with significant worsening of mechanical properties and protein composition after three or more consecutive treatments, emphasizing the need to consider the cumulative impacts of dyeing on hair health.
July 2024 in “Skin Appendage Disorders” This study reviews literature showing that trichotillomania significantly reduces quality of life and emphasizes that effective treatment requires an interdisciplinary approach involving dermatology and psychiatry to address its psychiatric component.
June 2024 in “Research Square (Research Square)” This study observed that combining botulinum toxin type A with Minoxidil significantly promoted hair growth, improved quality of life, and enhanced patient satisfaction in male androgenetic alopecia patients at 4 and 6 months, with no adverse effects compared to using Minoxidil alone.
May 2024 in “British Journal of Community Nursing” In this case series, researchers reviewed 38 case studies involving Prontosan® products for chronic lower limb ulcers and found that the treatments significantly improved wound healing and various quality of life outcomes, such as reduced malodour and pain, better mobility, and enhanced social life.
May 2024 in “KIU journal of health science” In this study, kolaviron and quercetin were found to reverse elevated biomarkers associated with testosterone-induced benign prostatic hyperplasia in Wistar rats, with both treatments effectively increasing HDL-c levels, though quercetin did not significantly affect triglyceride levels.
May 2024 in “International journal of medicine and psychology.” This study found that patients with chronic-stage true eczema and comorbid depression experienced a more severe disease progression, marked by higher inflammation levels and significantly reduced quality of life compared to those without depression.
May 2024 in “Nano letters” This study developed a quercetin-encapsulated and polydopamine-integrated nanosystem that reshapes the perifollicular microenvironment, showing potential for rescuing hair follicle viability and regenerating hair follicles in androgenic alopecia by scavenging reactive oxygen species and promoting angiogenesis.
April 2024 in “International journal of community medicine and public health/International journall of community medicine and public health” In this study, researchers found that female pattern hair loss significantly reduces quality of life, particularly affecting younger women who experience more stigmatization, poorer emotional stability, and higher dermatology life quality index scores compared to older women.
April 2024 in “Journal of Investigative Dermatology” This study identified three new genetic loci linked to sweat gland density in a GWAS involving 6,210 Han Chinese individuals, highlighting potential targets for understanding conditions like anhidrosis and hyperhidrosis and emphasizing the use of quantitative traits in genetic dermatology research.
April 2024 in “Assiut Scientific Nursing Journal” In this study, researchers assessed the quality of life in 70 patients with alopecia areata, finding that treatment choice and age positively correlated with quality of life, while factors like sex, education, and knowledge did not.